NEW YORK (AP) — NEW YORK (AP) — Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported a loss of $7.6 million in its first quarter.
On a per-share basis, the New York-based company said it had a loss of 19 cents.
The drug maker posted revenue of $2 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORMP at https://www.zacks.com/ap/ORMP
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
